While the majority of those with Noonan Syndrome carry germline mutations in RAS pathway genes (e.g., PTPN11, KRAS, NRAS, SOS-1, RAF1, BRAF), not all develop JMML. Here, KRAS is linked to juvenile myelomonocytic leukemia.